CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 230 enrolled
Drug / intervention
Water (Placebo) +3 moredrug
Likely dose
N-acetylcysteine 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01653171
NCT01653171Phase 4Completed

Effectiveness of Premedication With Simethicone or Simethicone Plus N-acetylcysteine vs. Placebo in Improving Visibility During Upper Endoscopy.

Pontificia Universidad Catolica de Chile·interventional·Posted Jul 30, 2012·Updated Apr 10, 2018

In Brief

A Phase 4 clinical trial evaluating Water (Placebo), Simethicone, and 2 other interventions for Stomach Neoplasms. Completed, enrolled 230 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether premedication with Simethicone or Simethicone plus N-acetylcysteine are effective improving visibility during Upper endoscopy compared with use of water or no preparation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChile
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJul 30, 2012
Enrollment StartJul 1, 2012
Primary CompletionOct 1, 2013
Study CompletionNov 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 13.9 years ago

Interventions

Water (Placebo)drug

Water 100 mL

Simethiconedrug

200 mg (5 mL) in water for up to 100 mL, to take 20 minutes prior to examination

N-acetylcysteine 500 mgdrug

500 mg + Simethicone 200 mg in water for up to 100 mL, to take 20 minutes prior to examination

N-acetylcysteine 1000 mgdrug

1000 mg + Simethicone 200 mg in water for up to 100 mL, to take 20 minutes prior to examination